Vicriviroc maleate

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HIVHIV Infections

Phase 2

Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)

CompletedNCT00686829

Merck Sharp & Dohme LLCHIV, HIV Infections

Start: 2005-06-30End: 2010-10-21Updated: 2020-12-03

Unknown Phase

Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

CompletedNCT00705419

Merck Sharp & Dohme LLCHIV Infections

Start: 2007-07-31End: 2010-09-30Updated: 2015-02-05